Introducing WCG. We’ve transformed from the inside out to ensure we’re streamlined and optimizing our value delivery to our clients. Our new brand represents the integration of our best-in-class legacy companies uniting as one and look embodies our identity as a leading provider of connectivity, data intelligence, and expertise for the advancement of clinical research. At WCG, our shared purpose is to bring life-saving therapies to those who need them and work toward our goal of accelerating clinical research. We are excited to embark on this new journey, moving forward as one. WCG, improving lives by accelerating clinical research, together. www.wcgclinical.com
WCG
Pharmaceutical Manufacturing
Princeton, New Jersey 30,172 followers
We improve lives by accelerating research, together.
About us
WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG’s 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy while improving quality outcomes and efficiency through the process. Ninety percent of all clinical trials leverage our knowledge, highly specialized solutions, and data-driven insights to mitigate risk today for a more promising tomorrow.
- Website
-
https://www.wcgclinical.com/
External link for WCG
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Princeton, New Jersey
- Type
- Privately Held
- Specialties
- Ethical Review, Clinical Trials, Study Start-Up Acceleration, Risk Mitigation, IRB, Consulting Services, Biosafety Solutions, GCP & Compliance Services, Expertise by Therapeutic Class, Oncology Research, eConsent, Part 11-Compliant Learning Management, and Global Services
Locations
Employees at WCG
Updates
-
With decades of experience, WCG is proud to be known for our IRB services. But did you know we bring the same level of expertise to every phase of the clinical trial journey? Discover WCG's eCOA/ePRO solution. We integrate cohesive, interoperable eCOA software with precise expert clinician services to enhance clinical study data collection, management, and analysis. This provides improved clinical assessment accuracy and a smoother, more direct path to market. Leverage industry-leading scientific measurement and data quality with WCG's eCOA/ePRO solution. Schedule a consultation at https://lnkd.in/ePZzyhSZ. #eCOA #ePRO #WCG #clinicalresearch #clinicaltrial
-
With WCG support, a top 5 pharma’s dermatology study was able to close enrollment 24 months ahead of schedule. The numbers speak for themselves. See our impact and how we did it. View the case study at https://lnkd.in/eR66_ggg
-
-
Available now: The 2024 Avoca State of the Industry Report – Anticipating ICH E6 (R3): Awareness, Impact & Preparedness. Regarding excerpts of proposed ICH E6 (R3) guidance, Roles and Responsibilities are seen as having the most potential to positively impact clinical trials by bringing much needed simplification and collaboration to trial design. A mixed response among sponsors/providers and sites is observed as it relates to Data Governance guidance, including lack of confidence in technology assessments and concerns about the impact to eligibility. Documentation and Records guidance appears to be the most “controversial” excerpt, as the draft language is considered vague and there is skepticism it will improve current practice. View the full report: https://lnkd.in/e7aC6NMe Avoca, A WCG Company #WCG #ClinicalTrials #ClinicalResearch #Report #ICHE6R3
-
-
WCG is proud to support the clinical trials industry with leading Recruitment & Retention strategies, helping sponsors overcome site challenges, and ensuring studies progress at the fastest rate possible. To learn more about WCG's Recruitment & Retention solutions, click the link below and one of our experts will reach out to find the right fit for your unique scenario. https://lnkd.in/ef9cJckf
Thanks Adrienne for co-authoring this with me! In the intricate landscape of clinical trials, adaptability and innovation are critical. At Merck, we have a relationship with WCG specifically for Site Augmentation Services, a global, patient recruitment provider, with a historic focus centered around individual protocol needs. However, the site resource challenges presented by the COVID-19 pandemic prompted us to reassess our strategy with WCG-Three Wire as the Great Resignation brought to light a pressing issue – the departure of study coordinators from sites, creating urgent resource gaps that demanded our attention. This recognition emphasized the challenges surrounding resource allocation within the clinical research landscape. In response to these challenges, our company took a proactive stance in finding a solution to bridge resource gaps. Our work with WCG evolved beyond individual protocol needs to support sites more comprehensively. "By addressing resource gaps and supporting sites, we focus on patients with unparalleled support and care," says Kelly White, Executive Director, Global Trial Optimization at Merck. The goal of working with WCG is to enhance the global clinical trial experience on multiple fronts - including patient education and enrollment, data entry and resolution, record management, and additional administrative support. In the past year, our company, under the enhanced working model with WCG, supported nearly 400 sites for Merck trials, expanding the footprint to more than 30 countries which covers greater than 50% of our footprint. “We identified an opportunity to contribute to a more efficient and patient-centric clinical trial experience by actively supporting the sites. Leveraging WCG, we are working with qualified personnel in diverse markets, to help ensure linguistic alignment and adherence to local regulations. This allows us to maintain cultural sensitivity and compliance across operational markets,” says Adrienne Walstrum, M.S.M., Director, Global Trial Optimization at Merck. Our work with WCG underscores our company’s unwavering commitment to driving positive change in the clinical trial landscape. By placing patients at the center of our initiatives and supporting sites comprehensively, we are dedicated to making a lasting impact on the clinical trial experience. #MerckProud #ClinicalTrials
-
-
Are you heading to Portland, Oregon for Joint Statistical Meetings? Connect with WCG! Our experts will be on the ground, ready to share how WCG is leveraging our 30+ years of experience to address your committee and statistical needs. DM one of our experts below for a 1:1 meeting at JSM or stop by our booth! Joshua Gentile, MBA Brian O'Neill #JSM #JSM2024 #JointStatisticalMeeting #WCG #clinicalresearch
-
-
#Connect with WCG at the Joint Statistical Meetings in Portland, Oregon, from August 3-8! Discover how WCG is leveraging our 30+ years of experience to address committee and statistical needs. DM one of our experts below for a 1:1 meeting at JSM or stop by our booth! Joshua Gentile, MBA Brian O'Neill #JSM #JSM2024 #JointStatisticalMeeting #WCG #clinicalresearch
-
-
Do you want to learn more about how feasibility and participant recruitment and retention play a pivotal role in the success of a #clinicaltrial? Watch our on-demand webinar "Maximizing Trial Success Requires Evolving Feasibility and Recruitment Strategies." AVAILABLE NOW! Hear WCG experts explore the competitive landscape and share actionable approaches on: ⚙Developing continuous site selection and recruitment strategies 📊Leveraging data and insights for site enrollment projection ⭐Instituting high-impact improvements on site selection and recruitment Access the insights now at https://lnkd.in/edrKnqQh #feasibility #recruitment #retention #WCG
-
-
Enhance your #clinicalresearch quality and regulatory expertise with MAGI@home! Understand and ensure adherence to the regulations on research participant protections with the Quality/Regulatory Track from MAGI@home. Join experts for insightful sessions, including: 🌎Ensuring quality in Real-world Evidence (RWE) 📝Back to the basics: Insights into regulatory guidelines and regulations 👀A two-part session on Preparing for FDA Audits: Are you ready when the FDA comes calling? 🔍Navigating the next steps of ICH E6(R3) 🤝Site feasibility: the critical role of stakeholder engagement Register for MAGI@home now at https://lnkd.in/eZ6Yqnam #WCG #MAGI #Quality #Regulatory #ClinicalTrial #ClinicalResearch #FDAaudit #SiteFeasibility
-
-
Access now: The 2024 Avoca State of the Industry Report – Anticipating ICH E6 (R3): Awareness, Impact & Preparedness. With the expectation of revised guidance under ICH E6 (R3) to be finalized in the fall of 2024, the topic of this year’s research focuses on understanding current awareness of proposed changes and gauging perceived impacts to sponsors, providers, and site personnel. Read insights and reactions to upcoming regulatory changes across clinical trial stakeholders to foster collaboration and successful implementation. Download the report: https://lnkd.in/e7aC6NMe Avoca, A WCG Company #WCG #ClinicalTrials #ClinicalResearch #Report #ICHE6R3
-